PMCB — PharmaCyte Biotech Inc · $8.6M cap

PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.

Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.

Use this PMCB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PMCB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PMCB SEC filings page. Lician reads the product cache first so this HTML stays unique to PharmaCyte Biotech Inc even when a live quote feed is slow.

PharmaCyte Biotech Inc latest statements (FY2026)

Latest cached year on this hub. Full PMCB income, balance, and cash tables.

  • Revenue$0
  • Net Income-$19.4M
  • Total Assets$46.8M
  • Total Debt$0
  • Free Cash Flow$0